NCT01023984

Brief Summary

Objective: Recent non-randomized studies suggest that extended endoscopic submucosal dissection (ESD) is equally effective in removing large rectal adenomas as transanal endoscopic microsurgery (TEM). If equally effective, ESD might be a more cost-effective approach as this strategy does not require expensive equipment, general anesthesia and hospital admission. Furthermore, ESD appears to be associated with fewer complications. In a randomized trial we will compare the cost-effectiveness and cost-utility of TEM and ESD for the resection of large rectal adenomas. Study design: 15 centers will participate in this multicenter randomized trial comparing TEM versus ESD. Study population: Patients with a large rectal adenoma (≥2cm), located between 2 and 15 cm from the anal verge. Invasive cancer is excluded by histopathology and endoscopic ultrasonography. Patients must be in a health condition that permits general anesthesia. Interventions: Patients will be randomized between a. TEM: under general anesthesia b. ESD under sedation

  1. 1.a TEM tube will be inserted in the rectum. With specialized instruments the adenoma will be dissected en bloc by a full thickness excision, after which the patient will be admitted to the hospital.
  2. 2.an endoscope will be inserted into the rectum and the submucosa underneath the lesion will be injected with saline to lift the adenoma. With an endoscopic knife (Insulated Tip Knife, Olympus or Water Jet, Erbe) the lesion will be resected through the submucosal plane in an eb-bloc fashion, after which the patient will be observed for at least 24h in-hospital.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jan 2012

Longer than P75 for phase_4

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 1, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 2, 2009

Completed
2.1 years until next milestone

Study Start

First participant enrolled

January 1, 2012

Completed
7.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2019

Completed
Last Updated

September 8, 2023

Status Verified

September 1, 2023

Enrollment Period

7.9 years

First QC Date

December 1, 2009

Last Update Submit

September 6, 2023

Conditions

Keywords

RECTAL NEOPLASMS

Outcome Measures

Primary Outcomes (1)

  • Incidence of recurrence at 12 months

    12 months

Secondary Outcomes (4)

  • Morbidity, subdivided into major (requiring surgery) and minor (requiring endoscopic or medical intervention)

    24 months

  • Anorectal function

    12 months

  • Disease specific and general quality of life

    12 months

  • Number of days not spent in hospital from initial treatment until 2 years afterwards

    12 months

Study Arms (2)

TEM - Transanal Endoscopic Microsurgery

ACTIVE COMPARATOR

TEM under general anesthesia

Procedure: TEM - Transanal Endoscopic Microsurgery

ESD - Endoscopic Submucosal Dissection

ACTIVE COMPARATOR

ESD under sedation

Procedure: ESD - Endoscopic Submucosal Dissection

Interventions

TEM tube will be inserted in the rectum. With specialized instruments the adenoma will be dissected en bloc by a full thickness excision, after which the patient will be admitted to the hospital.

TEM - Transanal Endoscopic Microsurgery

an endoscope will be inserted into the rectum and the submucosa underneath the lesion will be injected with saline to lift the adenoma. With an endoscopic knife (Insulated Tip Knife, Olympus or Water Jet, Erbe) the lesion will be resected through the submucosal plane in an eb-bloc fashion, after which the patient will be observed for at least 24h in-hospital.

ESD - Endoscopic Submucosal Dissection

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed with a large non-pedunculated rectal adenoma (sessile or flat) with a largest diameter of ≥2 cm (estimated by an opened resection snare of 20 or 30 mm).
  • The lower and upper borders of the adenoma are located at ≥2 cm and ≤15 cm from the anal verge, respectively.
  • During flexible video endoscopy there are no signs of endoscopic suspicion for submucosal invasive cancer (Kudo pit pattern type V; excavated/depressed type morphology; fold convergence; or large smooth nodule \>1 cm in a flat lesion) (33). In case of doubt, patients will undergo EUS as described at (2).
  • In case doubt remains after flexible video endoscopy, endoscopic ultrasonography (EUS) of the rectal adenoma should exclude invasion into the submucosal layer and exclude pathological lymphadenopathy (lymph nodes \>1 cm). When pathological lymph nodes are present, fine needle aspiration will be performed to exclude lymph node metastasis (N+ disease).
  • If not performed already, total colonoscopy will be done to detect and remove all synchronous colonic adenomas or cancers first. Cecal intubation must be confirmed by identification of the appendiceal orifice and ileocecal valve.
  • The general health condition of the patient permits general anesthesia (ASA- classification I-III).
  • Absence of non-correctable coagulopathy (international normalized ratio \>1,5, or platelet count \<90 × 109/l).
  • Patient age of 18 years or older.

You may not qualify if:

  • Preoperative histologically detected malignancy
  • Previous anorectal surgery
  • Contraindications to general anaesthesia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Torino

Torino, TO, 10126, Italy

Location

Related Publications (3)

  • Repici A, Conio M, De Angelis C, Sapino A, Malesci A, Arezzo A, Hervoso C, Pellicano R, Comunale S, Rizzetto M. Insulated-tip knife endoscopic mucosal resection of large colorectal polyps unsuitable for standard polypectomy. Am J Gastroenterol. 2007 Aug;102(8):1617-23. doi: 10.1111/j.1572-0241.2007.01198.x. Epub 2007 Mar 31.

    PMID: 17403075BACKGROUND
  • Bretagnol F, Merrie A, George B, Warren BF, Mortensen NJ. Local excision of rectal tumours by transanal endoscopic microsurgery. Br J Surg. 2007 May;94(5):627-33. doi: 10.1002/bjs.5678.

    PMID: 17335125BACKGROUND
  • Bach SP, Hill J, Monson JR, Simson JN, Lane L, Merrie A, Warren B, Mortensen NJ; Association of Coloproctology of Great Britain and Ireland Transanal Endoscopic Microsurgery (TEM) Collaboration. A predictive model for local recurrence after transanal endoscopic microsurgery for rectal cancer. Br J Surg. 2009 Mar;96(3):280-90. doi: 10.1002/bjs.6456.

    PMID: 19224520BACKGROUND

MeSH Terms

Conditions

Rectal Neoplasms

Condition Hierarchy (Ancestors)

Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesIntestinal DiseasesRectal Diseases

Study Officials

  • Mario Morino, Prof of Surgery

    University of Torino

    STUDY CHAIR
0

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Surgery

Study Record Dates

First Submitted

December 1, 2009

First Posted

December 2, 2009

Study Start

January 1, 2012

Primary Completion

December 1, 2019

Study Completion

December 1, 2019

Last Updated

September 8, 2023

Record last verified: 2023-09

Locations